Bessemer Group
VIR icon

Bessemer Group’s Vir Biotechnology VIR Stock Holding History

Bessemer Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Hold
207
– – ﹤0.01% 2403
2025
Q4 		$1K Buy
+207
New +$1.23K ﹤0.01% 2502
2025
Q3 		– Sell
-60
Closed – – 2742
2025
Q2 		$0 Hold
60
– – ﹤0.01% 2664
2025
Q1 		$0 Buy
+60
New +$533 ﹤0.01% 2735
2024
Q4 		– Sell
-140
Closed -$1K – 2707
2024
Q3 		$1K Buy
+140
New +$1.22K ﹤0.01% 2565
2023
Q3 		– Sell
-64
Closed -$2K – 2350
2023
Q2 		$2K Buy
+64
New +$1.61K ﹤0.01% 2086
2023
Q1 		– Sell
-140
Closed -$4K – 2175
2022
Q4 		$4K Hold
140
– – ﹤0.01% 1689
2022
Q3 		$3K Buy
+140
New +$3.56K ﹤0.01% 1876
2021
Q1 		– Hold
0
– – – 1677
2020
Q4 		– Hold
0
– – – 1583

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return